Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
J Invest Dermatol. 2012 Feb;132(2):401-9. doi: 10.1038/jid.2011.317. Epub 2011 Oct 20.
Primary human squamous cell carcinomas (SCCas) are heterogeneous invasive tumors with proliferating outer layers and inner differentiating cell masses. To determine if tumor-initiating cells (TICs) are present in SCCas, we utilized newly developed reliable in vitro and in vivo xenograft assays that propagate human SCCas, and demonstrated that a small subset of SCCa cells (∼1%) expressing Prominin-1 (CD133) in the outer layers of SCCas were highly enriched for TICs (∼1/400) compared with unsorted SCCa cells (TICs ∼1/10(6)). Xenografts of CD133+ SCCas recreated the original SCCa tumor histology and organizational hierarchy, whereas CD133- cells did not, and only CD133+ cells demonstrated the capacity for self-renewal in serial transplantation studies. We present a model of human SCCas in which tumor projections expand with outer leading edges that contain CD133+ TICs. Successful cancer treatment will likely require that the TICs identified in cancers be targeted therapeutically. The demonstration that TICs are present in SCCas and are enriched in a CD133- expressing subpopulation has not been, to our knowledge, previously reported.
原发性人鳞状细胞癌 (SCCas) 是具有增殖外层和内部分化细胞团的异质性浸润性肿瘤。为了确定 SCCas 中是否存在肿瘤起始细胞 (TICs),我们利用新开发的可靠的体外和体内异种移植检测方法来增殖人 SCCas,并证明 SCCas 外层中表达 Prominin-1 (CD133) 的一小部分 SCCa 细胞(约 1%)与未分选的 SCCa 细胞相比,TICs 高度富集(约 1/400)(TICs 约 1/10(6))。CD133+ SCCas 的异种移植物重现了原始 SCCa 肿瘤的组织学和组织层次结构,而 CD133-细胞则没有,只有 CD133+细胞在连续移植研究中表现出自我更新的能力。我们提出了一个人类 SCCas 的模型,其中肿瘤突起随着包含 CD133+TICs 的外层前缘扩展。成功的癌症治疗可能需要针对癌症中鉴定出的 TICs 进行靶向治疗。据我们所知,目前还没有报道过 TICs 存在于 SCCas 中并且富集在表达 CD133-的亚群中。